title: [Comparison of health education and drug therapy monitoring interventions in patients with cardiovascular risk factors attending a community pharmacy (FISFTES-PM Study)].
abstract: OBJECTIVE
  To compare health education (HE) and drug therapy monitoring (DTM) interventions in patients with cardiovascular risk factors (CVRF).
  
  
  METHODS
  Randomised experimental studys: 100 patients per group.
  
  
  METHODS
  Playa-Miramar pharmacy (Valencia, Spain). March 2010-November 2011.
  
  
  METHODS
  Patients with one or more CVRF detected based on medication they were taking or questions they asked when drugs were dispensed. Patients were assigned to one of the two groups (HE or DTM) using a random number table. 100 patients by group were included.
  
  
  METHODS
  Six months of DTM (DTMG) or health education (HEG) per patient.
  
  
  METHODS
  The primary variables were modifiable CVRF: hypertension, dyslipidaemia, diabetes, smoking, obesity and low physical activity. Secondary variables were non modifiable CVRF (age, sex, cardiovascular disease), heart rate, body mass index, waist measurement, waist-to-hip ratio, waist-to-height ratio, body fat, treatment compliance.
  
  
  RESULTS
  The differences in the reduction percentages were statistically greater in DTMG than in HEG for the following variables: systolic pressure 5.40% (p=0.001); heart rate 2.95%(p=0.015); weight 2.00% (p=0.002); BMI 2.24% (p=0.003); fasting glucose 8.65% (p=0.004); total cholesterol 6.45% (p=0.002); waist measurement 1.85% (p=0.010); and waist-to-height ratio 1.66% (p=0.002). Triglycerides and body fat were reduced by 12.78% (p<0.001) and 1.84% (p<0.001) more, respectively, in DTMG. These differences were not statistically significant.
  
  
  CONCLUSIONS
  The reduction percentages were generally higher for all variables in DTMG except diastolic blood pressure, which decreased by 4.7% (P<.001) more in HEG because the baseline values were higher.
authors.affiliation: Licenciada en Farmacia, Farmacéutica comunitaria, Farmacia de la Playa de Miramar, Valencia, España. Electronic address: mabopy@hotmail.com.
authors.forename: Patricia
authors.initials: P
authors.lastname: Bofí Martínez
authors.affiliation: Doctor en Farmacia, Farmacéutico comunitario, Huécija, Almería, Grupo de Investigación en Atención Farmacéutica, Universidad de Granada, Granada, España.
authors.forename: Emilio
authors.initials: E
authors.lastname: García Jiménez
authors.affiliation: Doctor en Farmacia, Responsable del Grupo de Investigación enAtención Farmacéutica, Universidad de Granada, Granada, España.
authors.forename: Fernando
authors.initials: F
authors.lastname: Martínez Martínez
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D003157:Community Pharmacy Services; D016903:Drug Monitoring; D005260:Female; D006266:Health Education; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
keywords: Cardiovascular disease; Community pharmacy; Drug therapy monitoring; Educación sanitaria; Enfermedades cardiovasculares; Farmacia comunitaria; Health education; Seguimiento farmacoterapéutico